Humacyte gets FDA authorization to extend Symvess shelf life to 36 months
FDA authorized extending Symvess expiration dating from 18 months to 36 months. Humacyte says the extended shelf life is supported by additional stability data showing Symvess meets established quality specifications through the 36-month period.
The FDA authorized an extension of Symvess expiration dating from 18 months to 36 months, Humacyte said. The longer shelf life is supported by additional stability data showing Symvess continues to meet all established quality specifications throughout the 36-month dating period. , Sept. 09, 2026 (GLOBE…